NCT03585699View on ClinicalTrials.gov

Percutaneous Fluoroscopic vs CT Guided Core Needle Biopsy for Spinal Infection and Tumor

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 1, 2016

Primary Completion Date

June 2, 2018

Study Completion Date

June 2, 2018

Conditions
SpondylodiskitisSpinal Tumor
Interventions
DIAGNOSTIC_TEST

Fluoroscopy Guided Spinal Biopsy

"Spinal biopsy done via Transpedicular approach with an 8-gauge T-Lok™ bone marrow biopsy needle under fluoroscopic guidance.~Samples collected were sent to laboratories for histopathological examination (HPE), culture and sensitivity (bacteriology, mycology and acid-fast bacilli), staining (Gram and Ziehl-Neelsen) and polymerase chain reaction (PCR) test for Mycobacterium tuberculosis."

DIAGNOSTIC_TEST

CT guided Spinal Biopsy

"Spinal biopsy done via Transpedicular approach with an 8-gauge T-Lok™ bone marrow biopsy needle under CT guidance.~Samples collected were sent to laboratories for histopathological examination (HPE), culture and sensitivity (bacteriology, mycology and acid-fast bacilli), staining (Gram and Ziehl-Neelsen) and polymerase chain reaction (PCR) test for Mycobacterium tuberculosis."

Trial Locations (1)

59100

University Malaya Medical Center, Kuala Lumpur

All Listed Sponsors
lead

University of Malaya

OTHER

NCT03585699 - Percutaneous Fluoroscopic vs CT Guided Core Needle Biopsy for Spinal Infection and Tumor | Biotech Hunter | Biotech Hunter